Stuart PeltzBoard Member/ Co-Founder PTC Therapeutics at NovMetaPharmaSpeaker
Agenda Sessions
Preserving Lean Mass in the GLP-1 Era: A First-in-Class CLIC1 Modulator Approach
, 13:40View Session

